Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/23/2867754/0/en/Epic-Bio-Presents-New-Data-Highlighting-Potential-of-EPI-321-for-FSHD-and-Epigenetic-Editing-Platform-Leadership-at-ASGCT-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/10/2861050/0/en/Epic-Bio-to-Participate-in-a-Fireside-Chat-at-the-Canaccord-Genuity-Genetic-Medicine-for-Generalists.html
https://www.globenewswire.com/news-release/2024/04/09/2860071/0/en/Epic-Bio-Announces-Robust-Slate-of-Presentations-at-the-American-Society-of-Gene-Cell-Therapy-ASGCT-27th-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/01/2855402/0/en/Epic-Bio-to-Participate-in-a-Fireside-Chat-at-the-Cantor-Virtual-Muscular-Dystrophy-Symposium.html
https://www.globenewswire.com//news-release/2024/03/13/2845820/0/en/Epic-Bio-to-Present-at-the-Upcoming-Charles-River-Cell-and-Gene-Therapy-Summit.html
https://www.globenewswire.com//news-release/2023/11/21/2784291/0/en/Epic-Bio-to-Present-at-the-Upcoming-CRISPR2-0-Conference.html
https://www.globenewswire.com//news-release/2023/11/16/2781654/0/en/FDA-Grants-Orphan-Drug-Designation-to-EPI-321-Epic-Bio-s-Novel-Genetic-Medicine-Candidate-for-Treatment-of-Facioscapulohumeral-Muscular-Dystrophy-FSHD.html
https://www.globenewswire.com//news-release/2023/11/07/2774828/0/en/Epic-Bio-to-Participate-in-Upcoming-Investor-Conference.html
https://endpts.com/kite-partners-with-epigenetic-editing-startup-epic-bio-in-car-t-work/